Patents by Inventor Rafik Abdelsayed

Rafik Abdelsayed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GILZ formulations for wound healing
    Patent number: 11524091
    Abstract: Glucocorticoid-induced leucine zipper protein (GILZ) peptide compositions and their methods of use in wound healing are disclosed herein. An exemplary GILZ peptide composition includes a GILZ fusion protein. The GILZ peptide compositions can be administered topically to wounds, for example in the form of a cream, ointment, or lotion. The GILZ peptide compositions can be used to treat acute wounds, induce wound healing in chronic wounds, and reduce scar formation.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: December 13, 2022
    Assignee: Augusta University Research Institute, Inc.
    Inventors: Mahmood Mozaffari, Babak Baban, Rafik Abdelsayed
  • Gilz Formulations for Wound Healing
    Publication number: 20200061237
    Abstract: Glucocorticoid-induced leucine zipper protein (GILZ) peptide compositions and their methods of use in wound healing are disclosed herein. An exemplary GILZ peptide composition includes a GILZ fusion protein. The GILZ peptide compositions can be administered topically to wounds, for example in the form of a cream, ointment, or lotion. The GILZ peptide compositions can be used to treat acute wounds, induce wound healing in chronic wounds, and reduce scar formation.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 27, 2020
    Inventors: Mahmood Mozaffari, Babak Baban, Rafik Abdelsayed
  • Compositions and methods for diagnosing and treating Sjogren's Syndrome
    Patent number: 9625445
    Abstract: Methods for detection and diagnosis of Sjögren's Syndrome in a subject, determining the stage or progression of Sjögren's Syndrome in a subject, determining the effectiveness of a treatment for Sjögren's Syndrome, and selecting a subject for treatment for Sjögren's Syndrome are disclosed. The methods typically include measuring the level of one or more Sjögren's Syndrome biomarkers in a biological sample obtained from a subject. Biomarkers for Sjögren's Syndrome include, but are not limited to, GADD153 and Del-1.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: April 18, 2017
    Assignee: Augusta University Research Institute, Inc.
    Inventors: Babak Baban, Mahmood Mozaffari, Rafik Abdelsayed, Jun Yao Liu
  • Compositions and Methods for Diagnosing and Treating Sjogren's Syndrome
    Publication number: 20140314715
    Abstract: Methods for detection and diagnosis of Sjögren's Syndrome in a subject, determining the stage or progression of Sjögren's Syndrome in a subject, determining the effectiveness of a treatment for Sjögren's Syndrome, and selecting a subject for treatment for Sjögren's Syndrome are disclosed. The methods typically include measuring the level of one or more Sjögren's Syndrome biomarkers in a biological sample obtained from a subject. Biomarkers for Sjögren's Syndrome include, but are not limited to, GADD153 and Del-1.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 23, 2014
    Applicant: Georgia Regents University
    Inventors: Babak Baban, Mahmood Mozaffari, Rafik Abdelsayed, Jun Yao Liu